Gilead released data showing that an HIV drug, called lenacapavir, could provide virtually complete protection against ...

A groundbreaking project to study potential HIV vaccines in several African countries has been derailed by an abrupt cut in funding from the United States government. As a result, several promising ...

An effective HIV-1 vaccine must therefore elicit antibodies that can neutralize many variants of the virus. While broadly neutralizing antibodies (bnAbs) have been isolated from HIV-1 infected ...

An annual jab to protect against HIV “shows potential”, according to an early study. Millions of people around the world are ...

The main symptom of chickenpox is an itchy, spotty rash that can be anywhere on the body. Chickenpox happens in three stages, ...

NanoViricides, Inc. (the “Company”)(NYSE American:NNVC), a clinical-stage global leader developing revolutionary broad-spectrum antiviral drugs that the viruses cannot escape, declared today that its ...

An American biochemist whose research has helped scientists make inroads on treating coronavirus and HIV has won this year’s ...

Sciences presented the first data from its ongoing Phase 1 study investigating two novel, once-yearly formulations of ...

Robert F. Kennedy Jr., President Donald Trump's former opponent in the 2024 election, was officially sworn in as Secretary of ...